PharmacoVigilance Monitoring System (PViMS)

An integrated approach to monitoring the safety of medicines that includes both active surveillance and spontaneous reporting is essential to a well-functioning pharmaceutical sector. Active surveillance is particularly important to support the introduction of new essential medicines in low-and middle-income countries, where regulatory systems are often still developing and need support. In such resource-limited settings, active surveillance can help determine the real-life frequency, risk factors, and impact of clinically significant adverse drug events on treatment outcomes in the population.

What is PViMS?

The PharmacoVigilance Monitoring System (PViMS) is a web-based application used by clinicians, regulatory bodies, and implementing partners to monitor the safety of medicines. PViMS enables the implementation of active surveillance activities in low- and middle-income countries (LMICs) by addressing the entire data collection, data analysis and reporting process. This allows decision makers to identify potential adverse events related to medicine use, and consequently implement decisions for improving patient safety. When used for spontaneous reporting, PViMS provides a comprehensive pharmacovigilance solution for LMIC. PViMS was developed by the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, implemented by Management Sciences for Health (MSH).

Features:

Languages

Available in English and French

Limitations

For more information, please contact communications@msh.org. View more pharmaceutical and supply chain management tools at https://www.mtapsprogram.org/tools/.